A Third COVID-19 Vaccine Dose in Kidney Transplant Recipients Induces Antibody Response to Vaccine and Omicron Variants but Shows Limited Ig Subclass Switching
J. Michelle Lee(Johns Hopkins University), Sabra L. Klein(Johns Hopkins University), Christine M. Durand(University of Maryland, Baltimore), Joel N. Blankson(Johns Hopkins University), Dorry L. Segev(New York University), Maggie Li(Johns Hopkins University), William A. Werbel(Johns Hopkins University), Camille Wouters(Johns Hopkins University), Andrew Pekosz(Johns Hopkins University), Aaron A.R. Tobian(Johns Hopkins University), Andrew H. Karaba(Johns Hopkins University), Jaiprasath Sachithanandham(Johns Hopkins University), Janna R. Shapiro(Office of International Affairs), Andrea L. Cox(Johns Hopkins University), John S. Lee(PhaseBio Pharmaceuticals (United States)), Ioannis Sitaris(Johns Hopkins University), Stephanie R Peralta(Johns Hopkins University), Mark A. Robien(National Institute of Allergy and Infectious Diseases)
Cited by 0
Related Papers
Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Foot strike patterns and collision forces in habitually barefoot versus shod runners
|Nature|2010|1.4k
Impact of sex and gender on COVID-19 outcomes in Europe
|Biology of Sex Differences|2020|1.4k
Clinical Practice Guidelines From the AABB
|JAMA|2016|1.1k